fbpx

 J&J Vision Expands Offering for 1-DAY ACUVUE® MOIST for ASTIGMATISM

Johnson & Johnson Vision announces the Canadian launch of expanded parameters for 1-DAY ACUVUE® MOIST Brand Contact Lenses for ASTIGMATISM, a daily disposable contact lens that offers patients Eyelid Stabilized Design for clear, stable vision and LACREON® Technology that provides a cushion of moisture for long-lasting comfort.

Nearly 1 out of every 2 vision corrected patients has astigmatism in at least one eye, and full correction can provide them with improved visual quality of life. With the addition of 48% more lens parameters for patients with astigmatism, the 1-DAY ACUVUE® MOIST Brand Contact Lens family now offers coverage for nearly 96% of spherical and astigmatic eyes3 and the ACUVUE® Family of 1-Day Contact Lenses for Astigmatism now offers the largest range of parameters among daily disposable contact lenses.

The proprietary Eyelid Stabilized Design found in 1-DAY ACUVUE® MOIST for ASTIGMATISM works naturally with the eyelids, helping to keep the lens in the correct position. LACREON® Technology embeds a moisture-rich wetting agent into the lens creating a cushion of moisture that won’t blink away over time. The result is reduced friction of the lens and greater end-of-day comfort.

1-DAY ACUVUE® MOIST for ASTIGMATISM provides Class II UV protection, blocking approximately 82% of UVA and 97% of UVB rays.

Click HERE for the full press release.

 

 

Featured Posts

Fighting Blindness Canada

First Patients Dosed in Gene Therapy Trial for USH1B

AAVantgarde Bio, an Italy-based biotechnology company announced that the first patient has been dosed in their Phase ½ clinical trial. This trial will test the safety of a new gene therapy (AAVB-081) for Usher Syndrome Type.

Learn More
Voila November-December 2024 Gigi Studios Isotta

GIGI STUDIOS’ ISOTTA: Timeless Elegance Meets Modern Craftsmanship

Introducing ISOTTA from our VANGUARD collection: a perfect blend of timeless elegance and modern craftsmanship.

Read more
Vision Expo new logo

Vision Expo East to Debut New Elevated Experiences and Events in Orlando

Vision Expo East is set to transform and inspire the optical industry with a reimagined show floor and enhanced programming at its inaugural Orlando edition.

Read more
Transitions Innovation awards 2025- logo

Transitions Optical Announces 2024 Transitions® Innovation Awards Finalists

Transitions Optical has unveiled the finalists for its annual Transitions® Innovation Awards program, which recognizes individuals and organizations from North America who have shown unparalleled commitment to implementing innovative programs and technologies over the past year.

Read more
Optical Women’s Association logo

The Optical Women’s Association Announces Global Connection Event at MIDO in Milan

The Optical Women’s Association (OWA) announces an OWA Global Event at MIDO in Milan, as expansion plans continue to reach out to women in the optical industry internationally.

Read more
Fighting Blindness Canada

First Patients Dosed in Gene Therapy Trial for USH1B

AAVantgarde Bio, an Italy-based biotechnology company announced that the first patient has been dosed in their Phase ½ clinical trial. This trial will test the safety of a new gene therapy (AAVB-081) for Usher Syndrome Type.

Learn More
Voila November-December 2024 Gigi Studios Isotta

GIGI STUDIOS’ ISOTTA: Timeless Elegance Meets Modern Craftsmanship

Introducing ISOTTA from our VANGUARD collection: a perfect blend of timeless elegance and modern craftsmanship.

Read More
Vision Expo new logo

Vision Expo East to Debut New Elevated Experiences and Events in Orlando

Vision Expo East is set to transform and inspire the optical industry with a reimagined show floor and enhanced programming at its inaugural Orlando edition.

Read More
Transitions Innovation awards 2025- logo

Transitions Optical Announces 2024 Transitions® Innovation Awards Finalists

Transitions Optical has unveiled the finalists for its annual Transitions® Innovation Awards program, which recognizes individuals and organizations from North America who have shown unparalleled commitment to implementing innovative programs and technologies over the past year.

Read More
Optical Women’s Association logo

The Optical Women’s Association Announces Global Connection Event at MIDO in Milan

The Optical Women’s Association (OWA) announces an OWA Global Event at MIDO in Milan, as expansion plans continue to reach out to women in the optical industry internationally.

Read More
Fighting Blindness Canada

First Patients Dosed in Gene Therapy Trial for USH1B

AAVantgarde Bio, an Italy-based biotechnology company announced that the first patient has been dosed in their Phase ½ clinical trial. This trial will test the safety of a new gene therapy (AAVB-081) for Usher Syndrome Type.

Learn More
Voila November-December 2024 Gigi Studios Isotta

GIGI STUDIOS’ ISOTTA: Timeless Elegance Meets Modern Craftsmanship

Introducing ISOTTA from our VANGUARD collection: a perfect blend of timeless elegance and modern craftsmanship.

Read more
Vision Expo new logo

Vision Expo East to Debut New Elevated Experiences and Events in Orlando

Vision Expo East is set to transform and inspire the optical industry with a reimagined show floor and enhanced programming at its inaugural Orlando edition.

Read more
Transitions Innovation awards 2025- logo

Transitions Optical Announces 2024 Transitions® Innovation Awards Finalists

Transitions Optical has unveiled the finalists for its annual Transitions® Innovation Awards program, which recognizes individuals and organizations from North America who have shown unparalleled commitment to implementing innovative programs and technologies over the past year.

Read more
Optical Women’s Association logo

The Optical Women’s Association Announces Global Connection Event at MIDO in Milan

The Optical Women’s Association (OWA) announces an OWA Global Event at MIDO in Milan, as expansion plans continue to reach out to women in the optical industry internationally.

Read more
Fighting Blindness Canada

First Patients Dosed in Gene Therapy Trial for USH1B

AAVantgarde Bio, an Italy-based biotechnology company announced that the first patient has been dosed in their Phase ½ clinical trial. This trial will test the safety of a new gene therapy (AAVB-081) for Usher Syndrome Type.

Learn More
Voila November-December 2024 Gigi Studios Isotta

GIGI STUDIOS’ ISOTTA: Timeless Elegance Meets Modern Craftsmanship

Introducing ISOTTA from our VANGUARD collection: a perfect blend of timeless elegance and modern craftsmanship.

Read more
Vision Expo new logo

Vision Expo East to Debut New Elevated Experiences and Events in Orlando

Vision Expo East is set to transform and inspire the optical industry with a reimagined show floor and enhanced programming at its inaugural Orlando edition.

Read more
Transitions Innovation awards 2025- logo

Transitions Optical Announces 2024 Transitions® Innovation Awards Finalists

Transitions Optical has unveiled the finalists for its annual Transitions® Innovation Awards program, which recognizes individuals and organizations from North America who have shown unparalleled commitment to implementing innovative programs and technologies over the past year.

Read more
Optical Women’s Association logo

The Optical Women’s Association Announces Global Connection Event at MIDO in Milan

The Optical Women’s Association (OWA) announces an OWA Global Event at MIDO in Milan, as expansion plans continue to reach out to women in the optical industry internationally.

Read more